NASDAQ: OCUL · Biotechnology
Over the past week, Ocular Therapeutix (OCUL) drew 3 mentions across Reddit, X and news, and the read is an Adanos Hold. That is too little tracked discussion to read a direction from, so the signal stays neutral. Wall Street is more constructive, with 11 of 11 analysts rating OCUL a buy.
Tracked discussion on OCUL is too thin this week to read a direction from, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from X at 0% to News at 100%. No other tracker puts the two side by side.
11 analysts have weighed in: a Strong Buy consensus: 11 buy calls against 0 sell, with an average 12-month price target of $27.09.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week OCUL carries too few tracked mentions to weigh any of them, so the read is Hold rather than a clear buy or sell.
Analysts sit 50 points above the crowd average of 50%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while X sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Ocular Therapeutix (OCUL) buzz held subdued around 26.8 while the price drifted down 14.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.1M shares. Updated Jul 27, 2026. Over the last 7 trading days, OCUL lost 7.2%. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 4 of the 5 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for OCUL and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live OCUL sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 27, 2026.
Adanos will not call Ocular Therapeutix (OCUL) either way right now. The last 7 days carry 3 tracked mentions across 2 sources, under the 10-mention floor, so the signal sits at a neutral hold with 40/100 conviction. This is a sentiment-based reading, not financial advice.
There is not enough tracked discussion on Ocular Therapeutix (OCUL) to call it either way. The last 7 days carry 3 tracked mentions across 2 sources, under the 10-mention floor Adanos needs before it reads a direction. On the professional side, 11 of 11 analysts rate OCUL a buy.
Of the 11 analysts covering Ocular Therapeutix (OCUL), 11 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $27.09. That puts the street ahead of the crowd, which averages 50% bullish.
Ocular Therapeutix (OCUL) does not carry enough tracked discussion this week to have a readable sentiment. 3 mentions across 2 sources is under the 10-mention floor, so the signal stays neutral at 40/100 conviction.
Not for a reason found in the sentiment itself. Ocular Therapeutix (OCUL) drew 3 tracked mentions in the last 7 days, too small a sample to read a direction from, so Adanos holds the signal neutral instead of calling a buy or sell off it.
News is the dominant discussion channel with 2 mentions (67% of total volume). X contributes 1 mention. There is too little of it to read a sentiment direction from.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. OCUL's hold signal at 40/100 conviction reflects a sample too thin to read a direction from. It is a research shortcut, not financial advice.
The OCUL sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Ocular Therapeutix with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an OCUL-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key